Kazia Therapeutics Limited KZIA
$ 5.79
4.7%
Annual report 2022
added 10-17-2022
Kazia Therapeutics Limited Balance Sheet 2011-2024 | KZIA
Annual Balance Sheet Kazia Therapeutics Limited
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | -5.43 M | -5.87 M | -14.4 M | -33.4 M | -44.4 M | 205 K | -1.32 M | - | - |
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
- | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
11.6 M | 11.9 M | 3.87 M | 5.08 M | 5.05 M | 5.19 M | 154 K | - | - | - | 7 K | 104 K |
Total Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
16.3 M | 20.2 M | 8.94 M | 6.98 M | 8.93 M | 10.6 M | 1.59 M | 1.78 M | 3.25 M | 1.71 M | 3.87 M | 8.31 M |
Deferred Revenue |
- | - | - | - | 138 K | 41 K | - | - | - | - | 1.08 M | 2.14 M |
Retained Earnings |
-68.3 M | -44.2 M | -36.2 M | -24.9 M | -14.6 M | -171 M | -161 M | -148 M | -141 M | -134 M | -192 M | -187 M |
Total Assets |
35 M | 58.1 M | 23.1 M | 21.2 M | 28.2 M | 35.9 M | 35.5 M | 46.1 M | 4.66 M | 5.75 M | 8.98 M | 12.7 M |
Cash and Cash Equivalents |
7.36 M | 27.6 M | 8.76 M | 5.43 M | 5.96 M | 14.5 M | 33.5 M | - | - | - | - | - |
Book Value |
18.6 M | 37.9 M | 14.1 M | 14.2 M | 19.2 M | 25.3 M | 33.9 M | 44.4 M | 1.41 M | 4.04 M | 5.11 M | 4.42 M |
Total Shareholders Equity |
18.6 M | 37.9 M | 14.1 M | 14.2 M | 19.2 M | 25.3 M | 33.4 M | - | - | - | - | - |
All numbers in AUD currency
Quarterly Balance Sheet Kazia Therapeutics Limited
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | 11.9 M | - | - | - | 3.87 M | - | - | - | 5.08 M | - | - | - | 5.05 M | - | - | - | 5.19 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | - | - | - | 20.2 M | - | - | - | 8.94 M | - | - | - | 6.98 M | - | - | - | 8.93 M | - | - | - | 10.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | - | - | - | - | -44.2 M | - | - | - | -36.2 M | - | - | - | -24.9 M | - | - | - | -14.6 M | - | - | - | -171 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
- | - | - | - | - | - | 58.1 M | - | - | - | 23.1 M | - | - | - | 21.2 M | - | - | - | 28.2 M | - | - | - | 35.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | - | - | - | - | - | 27.6 M | - | - | - | 8.76 M | - | - | - | 5.43 M | - | - | - | 5.96 M | - | - | - | 14.5 M | - | - | - | 33.5 M | - | - | - | 44.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
- | - | - | - | - | - | 37.9 M | - | - | - | 14.1 M | - | - | - | 14.2 M | - | - | - | 19.2 M | - | - | - | 25.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | - | - | - | - | - | 37.9 M | - | - | - | 14.1 M | - | - | - | 14.2 M | - | - | - | 19.2 M | - | - | - | 25.3 M | - | - | - | 33.9 M | - | - | - | 44.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in AUD currency